Literature DB >> 19289282

Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.

Jie Liu1, Jun Shiono, Kuniyoshi Shimizu, Akiko Kukita, Toshio Kukita, Ryuichiro Kondo.   

Abstract

Prostate cancer is the most common cancer in men in Western countries, with a high incidence of bone metastasis. Ganoderic acid DM, with 5alpha-reductase inhibitory and androgen receptor (AR) binding activity, isolated from the ethanol extracts of Ganoderma lucidum, can inhibit prostate cancer cell growth and block osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289282     DOI: 10.1016/j.bmcl.2009.02.119

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

Authors:  Benjamin M Johnson; Bently P Doonan; Faisal F Radwan; Azizul Haque
Journal:  Open Prost Cancer J       Date:  2010-01-01

Review 2.  Historical and current perspectives on therapeutic potential of higher basidiomycetes: an overview.

Authors:  Ruby Varghese; Yogesh Bharat Dalvi; Prasad Y Lamrood; Bharat P Shinde; C K K Nair
Journal:  3 Biotech       Date:  2019-09-17       Impact factor: 2.406

Review 3.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

4.  Ganoderic acid targeting multiple receptors in cancer: in silico and in vitro study.

Authors:  Balraj Singh Gill; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-09-03

5.  Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells.

Authors:  Benjamin M Johnson; Faisal F Y Radwan; Azim Hossain; Bently P Doonan; Jessica D Hathaway-Schrader; Jason M God; Christina V Voelkel-Johnson; Narendra L Banik; Sakamuri V Reddy; Azizul Haque
Journal:  J Cell Biochem       Date:  2018-10-30       Impact factor: 4.429

6.  Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats.

Authors:  Fang Wang; Zhongkai Zhou; Xiaochong Ren; Yuyang Wang; Rui Yang; Jinhua Luo; Padraig Strappe
Journal:  Lipids Health Dis       Date:  2015-05-22       Impact factor: 3.876

7.  Wild Mushrooms: A Potential Source of Nutritional and Antioxidant Attributes with Acceptable Toxicity.

Authors:  Sumaira Sharif; Muhammad Shahid; Muhammad Mushtaq; Sumia Akram; Ayoub Rashid
Journal:  Prev Nutr Food Sci       Date:  2017-06-30

8.  Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms.

Authors:  Jie Liu; Kuniyoshi Shimizu; Akinobu Tanaka; Wakako Shinobu; Koichiro Ohnuki; Takanori Nakamura; Ryuichiro Kondo
Journal:  Sci Rep       Date:  2012-11-30       Impact factor: 4.379

9.  Ganoderic Acid in the treatment of prostate cancer.

Authors:  Abdulghani Ameri
Journal:  Jundishapur J Nat Pharm Prod       Date:  2012-08-25

10.  Anticancer Activity of Ganoderic Acid DM: Current Status and Future Perspective.

Authors:  John Matthew Bryant; Mollie Bouchard; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2017-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.